Research with impact

Starpharma logo

MIPS partner, Starpharma, announces positive phase 1 clinical results for DEP® Docetaxel

11 October 2017

Scientists within Professor Chris Porter’s group at the ARC Centre of Excellence for Convergent Bio-Nano Science and Technology at the Monash Institute of Pharmaceutical

Medicine Manufacturing

MMIC Advisory Board to help Victorian Manufacturing Innovate

10 October 2017

Monash University’s Medicines Manufacturing Innovation Centre (MMIC) announced the members of its Industry Advisory Board. Following the announcement an expert panel asked if pharmaceutical

Rethink on beta blockers for heart attack survivors who take their other heart medication

20 September 2017

Beta blockers were found to offer no additional survival benefit for heart attack survivors who take two other medicines as prescribed, according to a new study involving Monash University’s Centre

Honorary doctorate conferred to ground-breaking biological scientist, Jean-Pierre Changeux

19 September 2017

Jean-Pierre Changeux, one of the world’s most eminent biological scientists, will receive the highest accolade from Monash University, an Honorary Doctorate (Doctor of Laws; Honoris Causa).

Professor William Charman

Professor William Charman receives Honorary Fellowship of the Royal Pharmaceutical Society

13 September 2017

Professor William Charman, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, has been made an Honorary Fellow of the Royal Pharmaceutical Society (RPS). The Honorary Fellowship was bestowed at a

Kirstie Galbraith

Monash recognised at International Pharmaceutical Federation Congress

12 August 2017

Associate Professor Kirstie Galbraith has been awarded an International Pharmaceutical Federation Fellowship at the FIP Congress in South Korea over the weekend. Also announced was the reappointment of

Dr Tony Velkov among stars of medical research

24 September 2015 

Dr Velkov presented with the National Health and Medical Research Council's Research Excellence Award for his work on polymyxin antibiotics.

Monash scientists gain multimillion-dollar NIH grant for ‘superbug’ drug discovery program

August 2017

A world-leading team, led by Professor Jian Li from the Monash Biomedicine Discovery Institute (BDI), has been awarded a multi-million dollar grant